Correlation Between Singular Health and Microequities Asset

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Singular Health and Microequities Asset at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Singular Health and Microequities Asset into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Singular Health Group and Microequities Asset Management, you can compare the effects of market volatilities on Singular Health and Microequities Asset and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Singular Health with a short position of Microequities Asset. Check out your portfolio center. Please also check ongoing floating volatility patterns of Singular Health and Microequities Asset.

Diversification Opportunities for Singular Health and Microequities Asset

-0.02
  Correlation Coefficient

Good diversification

The 3 months correlation between Singular and Microequities is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Singular Health Group and Microequities Asset Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Microequities Asset and Singular Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Singular Health Group are associated (or correlated) with Microequities Asset. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Microequities Asset has no effect on the direction of Singular Health i.e., Singular Health and Microequities Asset go up and down completely randomly.

Pair Corralation between Singular Health and Microequities Asset

Assuming the 90 days trading horizon Singular Health Group is expected to generate 2.82 times more return on investment than Microequities Asset. However, Singular Health is 2.82 times more volatile than Microequities Asset Management. It trades about 0.08 of its potential returns per unit of risk. Microequities Asset Management is currently generating about 0.02 per unit of risk. If you would invest  4.20  in Singular Health Group on August 25, 2024 and sell it today you would earn a total of  6.80  from holding Singular Health Group or generate 161.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.63%
ValuesDaily Returns

Singular Health Group  vs.  Microequities Asset Management

 Performance 
       Timeline  
Singular Health Group 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Singular Health Group are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical and fundamental indicators, Singular Health unveiled solid returns over the last few months and may actually be approaching a breakup point.
Microequities Asset 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Microequities Asset Management has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, Microequities Asset is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Singular Health and Microequities Asset Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Singular Health and Microequities Asset

The main advantage of trading using opposite Singular Health and Microequities Asset positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Singular Health position performs unexpectedly, Microequities Asset can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microequities Asset will offset losses from the drop in Microequities Asset's long position.
The idea behind Singular Health Group and Microequities Asset Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
CEOs Directory
Screen CEOs from public companies around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance